Medpace Holdings (MEDP) Receivables - Other (2015 - 2026)
Medpace Holdings' (MEDP) quarterly Receivables - Other came in at $21.3 million in Q2 2026, up 254.24% on a YoY basis from $6.0 million in Q2 2025, and down 12.14% quarter-over-quarter from $24.2 million in Q1 2026.
Analysis
Medpace Holdings (MEDP) Receivables - Other (2015 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has reported Receivables - Other for 12 consecutive years, with $21.3 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Receivables - Other rose 254.24% year-over-year to $21.3 million; the trailing twelve-month figure through Jun 2026 stood at $21.3 million (up 254.24% YoY), and the FY2025 full-year result was $25.4 million, up 5.2% from the prior year.
- Receivables - Other eased to $21.3 million in Q2 2026 per MEDP's latest filing, from $24.2 million in the prior quarter.
- Across five years, Receivables - Other topped out at $43.8 million in Q2 2022 and bottomed at $6.0 million in Q2 2025.
- Historically, Receivables - Other has averaged $23.7 million across 5 years, with a median of $24.2 million in 2024.
- The sharpest annual moves came in 2024 and 2026: Receivables - Other sank 81.09% in 2024, then soared 282.7% in 2026.
- Over 5 years, Receivables - Other stood at $40.4 million in 2022, then tumbled by 76.49% to $9.5 million in 2023, then soared by 153.68% to $24.1 million in 2024, then climbed by 5.2% to $25.4 million in 2025, then declined by 16.12% to $21.3 million in 2026.
- According to Business Quant data, Receivables - Other over the past three periods registered $21.3 million, $24.2 million, and $25.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.27 Mn |
| Mar 31, 2026 | 24.20 Mn |
| Dec 31, 2025 | 25.35 Mn |
| Sep 30, 2025 | 10.72 Mn |
| Jun 30, 2025 | 6.00 Mn |
| Mar 31, 2025 | 6.32 Mn |
| Dec 31, 2024 | 24.10 Mn |
| Sep 30, 2024 | 6.71 Mn |
| Jun 30, 2024 | 8.92 Mn |
| Mar 31, 2024 | 8.60 Mn |
| Dec 31, 2023 | 9.50 Mn |
| Sep 30, 2023 | 35.49 Mn |
| Jun 30, 2023 | 31.67 Mn |
| Mar 31, 2023 | 41.93 Mn |
| Dec 31, 2022 | 40.41 Mn |
| Sep 30, 2022 | 41.46 Mn |
| Jun 30, 2022 | 43.79 Mn |
| Mar 31, 2022 | 39.62 Mn |
| Dec 31, 2021 | 36.11 Mn |
| Sep 30, 2021 | 41.28 Mn |